NEW YORK (GenomeWeb) – NeoGenomics reported Wednesday morning that fourth quarter revenues grew 12 percent, fueled by strong growth in clinical genetic testing volume and pharmaceutical services.

For the three months ended Dec. 31, 2017, NeoGenomics reported revenues of $67.8 million compared to $60.5 million in the same quarter last year, beating the average analyst estimate of $66.3 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The US National Institutes of Health has developed guidelines to gauge whether frail chimpanzees are healthy enough to be moved to a retirement sanctuary.

Osamu Shimomura, who won the 2008 Nobel Prize in Chemistry for his work on green fluorescent protein, has died.

In PLOS this week: analytical approach for finding new genetic associations, analysis of Streptococcus pyogenes-infecting viruses, and more.

Stat News reports that the head of IBM Watson Health is leaving her post.